Resolution for winding up (CVL)
THE PRP LAB LIMITED
The PRP LAB LIMITED resolved to voluntarily wind up the company and appointed Yiannis Koumettou and Amie Helen Johnson as joint liquidators on 21 August 2026.
Notice details
- Company
- THE PRP LAB LIMITED
- Company number
- 11033243
- Registered office
- Suite 501, Unit 2, 94A Wycliffe Road, Northampton, NN1 5JF
- Principal trading address
- 22 Seymour Street, London, W1H 7HY
- Type of liquidation
- Voluntary winding-up
- Office holder(s)/Liquidator(s)
- Yiannis Koumettou; Amie Helen Johnson
- Office holder number(s)
- 015676; 018570
- Date of appointment
- 21 August 2026
- Contact
- Rob Jones, 0208 370 7250, [email protected]
How does this notice affect you?
Choose what applies and we'll point you at the right next step.
A written-off invoice rarely stops at the company that failed. The supplier left short is often the next business in difficulty — and the earlier that's dealt with, the more options stay open. If THE PRP LAB LIMITED owed you money, it's worth checking where that leaves you.
Unpaid wages, holiday pay and statutory redundancy are claimed from the government's Redundancy Payments Service, not from K2. The insolvency practitioner named in this notice should send you a case reference — you'll need it to claim.
K2 has backed and restructured UK businesses since 1990, including buying trade and assets out of distress. These situations move in days rather than months, so if you're looking at THE PRP LAB LIMITED or something similar, start the conversation early.
If your business is under pressure — creditors circling, a petition threatened, or cash running out — acting early changes the outcome. K2 has helped UK directors turn things around since 1990. Talk to us in confidence.
Related guidance
Free, practical guides from K2 on what this kind of notice means for directors.
More liquidation notices
Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.